Lymph nodes & spleen, nonlymphoma

Lymph node & spleen-nonlymphoid neoplasms

EBV positive inflammatory follicular dendritic cell / fibroblastic reticular cell tumor



Last author update: 5 January 2024
Last staff update: 28 August 2024

Copyright: 2023, PathologyOutlines.com, Inc.

PubMed Search: EBV positive inflammatory cell tumor

João Víctor Alves de Castro, M.D.
Elaine S. Jaffe, M.D.
Page views in 2023: 418
Page views in 2024 to date: 1,451
Cite this page: Alves de Castro JV, Jaffe ES. EBV positive inflammatory follicular dendritic cell / fibroblastic reticular cell tumor. PathologyOutlines.com website. https://www.pathologyoutlines.com/topic/lymphnodesEBVposinflamm.html. Accessed December 16th, 2024.
Definition / general
  • Epstein-Barr virus (EBV) positive inflammatory follicular dendritic cell (FDC) / fibroblastic reticular cell (FRC) tumor (ICC, 2022) / EBV positive inflammatory follicular dendritic cell (FDC) sarcoma (WHO, 5th edition) is an EBV driven indolent malignancy of FDC / FRC phenotype with a prominent inflammatory background
  • Encompasses extranodal lesions previously referred to as EBV positive inflammatory pseudotumor (IPT); nodal EBV positive IPT as well as EBV negative FDC sarcoma are excluded
Essential features
  • Extranodal EBV positive mesenchymal neoplasm with a phenotypic spectrum ranging from FDCs to FRCs associated with a prominent polymorphic inflammatory background
  • Previously considered a variant of FDC sarcoma, it has now been recognized as a distinct entity by both the WHO, 5th edition and the ICC, 2022
  • Nodal cases reported as inflammatory pseudotumor are excluded
  • Usually involves middle aged women of Asian descent
  • Solitary, asymptomatic splenic mass is the most common finding but it can also affect the liver and rarely, the colon and pancreas
Terminology
  • Inflammatory pseudotumor of the spleen, EBV positive
  • Inflammatory pseudotumor-like follicular / fibroblastic dendritic cell sarcoma
  • Inflammatory pseudotumor-like follicular dendritic cell tumor
ICD coding
  • ICD-O: 9758/3 - follicular dendritic cell sarcoma
  • ICD-10: C96.7 - other specified malignant neoplasms of lymphoid, hematopoietic and related tissue
  • ICD-11: 2B31.Y - other specified histiocytic or dendritic cell neoplasms
Epidemiology
Sites
Pathophysiology
Etiology
  • Neoplastic cells are positive for EBV encoded small RNA (EBER)
  • Frequent association with EBV genotype A, f variant and with a 30 base pair deletion in exon 3 of the LMP1 gene, demonstrating the presence of a clonal EBV genome (Histopathology 2016;69:883)
    • This implies that EBV plays a role in the etiology of these lesions
Clinical features
  • Usually asymptomatic finding during imaging work up for other reasons
  • Systemic symptoms can be seen, including fever, fatigue and weight loss
  • Abdominal distension and pain with or without palpable abdominal mass
  • Colonic cases can present with positive fecal occult blood test (Am J Surg Pathol 2021;45:765)
Diagnosis
  • Clinical, laboratory and imaging findings are largely nonspecific
  • Endoscopy shows a polypoid mass in cases involving the GI tract (Hum Pathol 2015;46:1956)
  • Diagnosis requires histopathological demonstration of characteristic morphology, immunophenotype and EBER positivity by the WHO criteria; these are best evaluated on excisional specimens, including splenectomies
Laboratory
  • Nonspecific inflammatory reaction, including anemia, hypergammaglobulinemia, elevated C reactive protein
Radiology description
Radiology images

Images hosted on other servers:
Liver mass on MRI

Liver mass on MRI

Prognostic factors
  • EBV positive FDC / FRC is an indolent tumor with a propensity for local recurrences in later stages of the disease
  • Location seems to be important for the prognosis, with splenic cases showing fewer recurrences than cases in the liver (Int J Clin Exp Pathol 2014;7:2421, Am J Surg Pathol 2001;25:721)
  • Distant metastases are rare and have been reported in the lungs and the spine
  • Overall mortality rate is 10% for liver cases
  • Colonic cases do not seem to recur and can be cured by complete excision (Hum Pathol 2015;46:1956)
Case reports
Treatment
Gross description
Gross images

Contributed by Elaine S. Jaffe, M.D.
Splenic mass

Splenic mass



Images hosted on other servers:
Solitary splenic nodule

Solitary splenic nodule

Pancreatic nodule

Pancreatic nodule

Microscopic (histologic) description
  • Neoplastic cells are spindled to oval, with vesicular chromatin, a small, central nucleolus and indistinct cytoplasmic borders
  • Binucleate cells with a kissing nuclei appearance can be noted in cases with FDC differentiation
  • Neoplastic cells form loose fascicles with a storiform appearance
  • Rich inflammatory background composed of small lymphocytes, plasma cells and histiocytes; eosinophils can be present (Hum Pathol 1995;26:1093, Am J Surg Pathol 2001;25:721)
  • In some cases, the inflammatory component can obscure the sparsely distributed neoplastic cells
  • Cytologic atypia is variable; it can range from subtle, with cells showing delicate nuclear membranes, to prominent with Hodgkin / Reed-Sternberg (HRS)-like cells (Am J Surg Pathol 2001;25:721)
  • Necrosis can be seen and it has not been consistently associated with more aggressive behavior (Am J Surg Pathol 2001;25:721, Histopathology 2016;69:883, Am J Surg Pathol 2021;45:765)
  • Cases referred to as having a hemangioma-like appearance due to the prominence of blood vessel wall hyaline and fibrinoid degeneration have been reported (Am J Surg Pathol 2023;47:476)
Microscopic (histologic) images

Contributed by Elaine S. Jaffe, M.D., Shunyou Gong, M.D., Ph.D. and João Víctor Alves de Castro, M.D.
Spindle cells in an inflammatory background

Spindle cells in an inflammatory background

Cytologic features and background

Cytologic features and background

Fibrinoid necrosis

Fibrinoid necrosis

Colonic lesion

Colonic lesion

Interface between spleen and tumor

Interface between spleen and tumor


Vascular damage and granulomas

Vascular damage and granulomas

Inflammatory background obscuring neoplastic cells Inflammatory background obscuring neoplastic cells

Inflammatory background obscuring neoplastic cells

SMA immunohistochemistry

SMA IHC

Double staining for SMA / EBER

Double staining for SMA / EBER

Cytology description
  • Fine needle aspiration biopsy smears, touch imprints and scrape preparations show spindle cells with vesicular, atypical nuclei and delicate cytoplasmic processes distributed singly or in syncytial clusters (Diagn Cytopathol 2008;36:42)
  • Nuclear grooves and prominent nucleoli can be seen
  • Cellularity ranges from hypo to hypercellular smears
  • Background is polymorphic and is rich in lymphocytes, plasma cells and histiocytes; can be hemorrhagic or necrotic
  • Immunohistochemistry is mandatory for the diagnosis (see Positive stains)
Cytology images

Images hosted on other servers:
Syncytial group of tumor cells

Syncytial group of tumor cells

Positive stains
Molecular / cytogenetics description
  • ALK and other tyrosine kinase gene rearrangements are negative by FISH and sequencing methods, including NGS
Molecular / cytogenetics images

Contributed by João Víctor Alves de Castro, M.D. and Elaine S. Jaffe, M.D.
EBER ISH

EBER ISH

EBER positive spindle cells

EBER positive spindle cells

Sample pathology report
  • Liver, left, partial hepatectomy:
    • Epstein-Barr virus (EBV) positive inflammatory follicular dendritic cell / fibroblastic reticular cell tumor (ICC, 2022) / EBV positive inflammatory follicular dendritic cell sarcoma (see comment)
    • Comment: Histologic sections reveal effacement of the liver architecture within the grossly described mass by an atypical lymphoplasmacytic infiltrate. The infiltrate is composed predominantly of small lymphocytes with mature chromatin and numerous plasma cells. There are rare scattered atypical cells with elongated nuclei. Fibrinoid deposition is present around several vessels in addition to areas of hyalinization. Within the areas of hyalinization, there are numerous large vessels. While scattered islands of hepatocytes are present, normal portal areas with bile ducts within the mass lesion are rare.
    • Within the lesion, there are rare scattered atypical, spindled appearing cells that are positive for CD21 and more often SMA. Clusterin is focally positive. CD20 and CD3 highlight B and T cells in aggregates respectively, with a predominance of T cells. EBV ISH highlights numerous cells, some with a spindled morphology and others that are more rounded. CD34 and SMA highlight sinusoidal spaces while keratin 7 highlights bile ducts, which are decreased in amount.
    • Given the patient's clinical presentation in conjunction with rare CD21, SMA and EBV positive spindled cells in the mass lesion, this case is best felt to represent an Epstein-Barr virus (EBV) positive inflammatory follicular dendritic cell / fibroblastic reticular cell tumor (ICC, 2022) / EBV positive inflammatory follicular dendritic cell sarcoma. The vessels and pattern of bile duct loss within the lesion are unusual. It is unclear whether the EBV positive spindle cell proliferation has distorted the underlying liver parenchyma, which then adapted to a predominantly arterial supply.
    • Epstein-Barr virus (EBV) positive inflammatory follicular dendritic cell / fibroblastic reticular cell tumor is the terminology currently used for the lesion also known as inflammatory pseudotumor. These occur in extranodal locations, including spleen, liver and more rarely GI tract. While previously referred to as sarcoma, when localized, the process has a good prognosis without significant risk for dissemination. This is an EBV driven lesion, in which the EBV positive cells are thought to be either FDCs or fibroblastic reticular cells (SMA positive).
Differential diagnosis
Board review style question #1

Epstein-Barr virus (EBV) positive inflammatory follicular dendritic cell / fibroblastic reticular cell tumor (ICC, 2022) / EBV positive inflammatory follicular dendritic cell sarcoma (WHO, 5th edition), previously referred to as EBV positive inflammatory pseudotumor (IPT), has been separated from EBV negative lesions that might also be termed IPT. Which of the following is compatible with the diagnosis of EBV positive FDC / FRC?

  1. Inflammatory background usually lacks plasma cells
  2. Lesion should be nodal in presentation, infrequently involving the spleen or liver
  3. Negative results for LMP1
  4. Neoplastic cells should have a distinct immunophenotype compatible with both follicular dendritic cell and fibroblastic reticular cell differentiation
  5. This lesion has a good prognosis, differing from the aggressive FDC sarcoma (EBV negative)
Board review style answer #1
E. This lesion has a good prognosis, differing from the aggressive FDC sarcoma (EBV negative). EBV positive inflammatory FDC / FRC tumor (ICC, 2022) / sarcoma (WHO, 5th edition) is an indolent neoplasm, in contrast to the aggressive FDC sarcoma. Answer B is incorrect because the lesion should be extranodal. Answer C is incorrect because EBV positivity is an essential criterion usually detected by EBER, but LMP1 can also be detected in many cases. Answer D is incorrect because the immunophenotype is highly variable and can be of either FDC or FRC derivation. Answer A is incorrect because the inflammatory background is important for the diagnosis and usually has prominent plasma cells.

Comment Here

Reference: EBV positive inflammatory follicular dendritic cell / fibroblastic reticular cell tumor
Back to top
Image 01 Image 02